4-hydroxycyclophosphamide has been researched along with Lupus Nephritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YC; Gu, Y; Hao, CM; Lai, LY; Lin, SY; Wang, HN; Xie, QH; Xue, J; Zhao, M; Zhu, XY; Zhu, Y | 1 |
1 other study(ies) available for 4-hydroxycyclophosphamide and Lupus Nephritis
Article | Year |
---|---|
The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients.
Topics: Adult; Aged; Cyclophosphamide; Female; Glutathione Transferase; Heterozygote; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Remission Induction; Treatment Outcome; Young Adult | 2015 |